Abbott announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), granted a positive opinion recommending approval of HUMIRA? (adalimumab) for the treatment of severe Crohn’s disease.
An anti-reflux valve developed to help esophageal cancer patients also has been shown to help those with bile duct obstruction, according to Kulwinder S. Dua, M.D., a research physician at the Medical College of Wisconsin in Milwaukee.
?”Children are like snowflakes, each one different, each one needing a different biomedical intervention,” said Shelley Reynolds of Unlocking Autism. ?”What makes treating autism difficult is that each combination to unlock each person affected is so unique.” As a result of advocacy efforts, the U.S. Congress provided $7.5 million in appropriations directed to the Department of Defense to initiate the Autism Spectrum Disorder Research Program in 2007.
An anti-reflux valve developed to help esophageal cancer patients also has been shown to help those with bile duct obstruction, according to Kulwinder S. Dua, M.D., a research physician at the Medical College of Wisconsin in Milwaukee.
A new study says targeting smaller (??5 mm) lesions does little to significantly reduce the incidence of colorectal cancer (CRC) and, in fact, results in extremely high financial costs and a large proportion of adverse events.
Genentech and FDA notified healthcare professionals of important new safety information regarding tracheoesophageal (TE) fistula formation in a recent clinical study in patients with limited-stage small cell lung cancer (SCLC).
Consumers who have purchased raw milk from Fisher’s Dairy, Butler County, any time after April 9, 2007, should discard it immediately due to the risk of Listeria monocytogenes contamination, Agriculture Secretary Dennis Wolff said.
Preliminary results from a large, randomized, placebo-controlled clinical trial for patients with primary gastrointestinal stromal tumor (GIST), a type of tumor usually found in the stomach or small intestine, showed that patients who received imatinib mesylate (Gleevec ?) after complete removal of their tumor were significantly less likely to have a recurrence of their cancer compared to those who did not receive imatinib.
New, updated guidelines for esophageal reflux testing appear in the American Journal of Gastroenterology. Developed and approved by the American College of Gastroenterology, these guidelines summarize advances in gastroesophageal reflux disease diagnostic testing and how they have modified the clinical management of esophageal disorders.
Gleevec, a pill developed in conjunction with Oregon Health & Science University is again showing excellent results in preventing cancer recurrence in GIST patients after complete removal of their tumors.